Strategies for disease-specific programmes 2010–2013
This document sets out the strategic priorities for all six ECDC disease-specific programmes from 2010 to 2013 based on a short description of the epidemiological background, context in which ECDC works on that specific disease or disease group, and defined gaps that require action at the European Union (EU) level.
Enhancing Reporting of after Action Reviews of Public Health Emergencies to Strengthen Preparedness: A Literature Review and Methodology Appraisal
Davies, R., Vaughan, E., Fraser, G., Cook, R., Ciotti, M., Suk, J.E.
Conducting in-action and after-action reviews of the public health response to COVID-19
This document aims to support the implementation of after-action reviews (AARs) and in-action reviews (IARs) focused on the public health response to COVID-19.
HEPSA – health emergency preparedness self-assessment tool, User guide
HEPSA is used to evaluate levels of preparedness, identify potential gaps, identify vulnerabilities, and detect areas for improvement – with the goal to strengthen overall preparedness capacities for public health emergencies. This user guide provides basic information on the self-assessment process.
Guidelines for the use of non-pharmaceutical measures to delay and mitigate the impact of 2019-nCoV
This document provides guidance on the application of non-pharmaceutical countermeasures to minimise the spread of the 2019 novel coronavirus (2019-nCoV) in the population. Some of the measures proposed refer specifically to certain phases of the epidemic (containment or mitigation phases), and can be adapted depending on the assessed severity/impact of the infection. Other measures are valid for all phases of an epidemic.
Guidance for health system contingency planning during widespread transmission of SARS-CoV-2 with high impact on healthcare services
This document aims to support public health preparedness planning and response activities when advising healthcare services on approaches on how to increase capacity for managing COVID-19 cases in the context of widespread sustained SARS-CoV-2 transmission in a particular community.